IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic targetNicolaus Bruns, Mehdi Farokhnia, Lorenzo Leggio et al.|Pharmacological Research|2024Cited by 75